vs
Side-by-side financial comparison of Globalstar, Inc. (GSAT) and STEM, INC. (STEM). Click either name above to swap in a different company.
Globalstar, Inc. is the larger business by last-quarter revenue ($72.0M vs $47.1M, roughly 1.5× STEM, INC.). Globalstar, Inc. runs the higher net margin — -16.1% vs -33.9%, a 17.7% gap on every dollar of revenue. On growth, Globalstar, Inc. posted the faster year-over-year revenue change (17.6% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 12.9%).
Globalstar, Inc. is an American telecommunications company that operates a satellite constellation in low Earth orbit (LEO) for satellite phone, low-speed data transmission and Earth observation. The Globalstar second-generation constellation consists of 25 satellites.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
GSAT vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $72.0M | $47.1M |
| Net Profit | $-11.6M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | -0.5% | -17.7% |
| Net Margin | -16.1% | -33.9% |
| Revenue YoY | 17.6% | -15.6% |
| Net Profit YoY | 76.9% | 68.8% |
| EPS (diluted) | $-0.11 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $72.0M | $47.1M | ||
| Q3 25 | $73.8M | $38.2M | ||
| Q2 25 | $67.1M | $38.4M | ||
| Q1 25 | $60.0M | $32.5M | ||
| Q4 24 | $61.2M | $55.8M | ||
| Q3 24 | $72.3M | $29.3M | ||
| Q2 24 | $60.4M | $34.0M | ||
| Q1 24 | $56.5M | $25.5M |
| Q4 25 | $-11.6M | $-16.0M | ||
| Q3 25 | $1.1M | $-23.8M | ||
| Q2 25 | $19.2M | $202.5M | ||
| Q1 25 | $-17.3M | $-25.0M | ||
| Q4 24 | $-50.2M | $-51.1M | ||
| Q3 24 | $9.9M | $-148.3M | ||
| Q2 24 | $-9.7M | $-582.3M | ||
| Q1 24 | $-13.2M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | -0.5% | -17.7% | ||
| Q3 25 | 13.8% | -33.6% | ||
| Q2 25 | 9.2% | -34.8% | ||
| Q1 25 | -14.2% | -65.0% | ||
| Q4 24 | -6.9% | -84.4% | ||
| Q3 24 | 13.0% | -493.2% | ||
| Q2 24 | -2.4% | -1705.5% | ||
| Q1 24 | -8.3% | -267.0% |
| Q4 25 | -16.1% | -33.9% | ||
| Q3 25 | 1.5% | -62.2% | ||
| Q2 25 | 28.6% | 527.8% | ||
| Q1 25 | -28.9% | -76.9% | ||
| Q4 24 | -82.1% | -91.6% | ||
| Q3 24 | 13.7% | -506.3% | ||
| Q2 24 | -16.0% | -1712.6% | ||
| Q1 24 | -23.4% | -283.9% |
| Q4 25 | $-0.11 | $-4.40 | ||
| Q3 25 | $-0.01 | $-2.84 | ||
| Q2 25 | $0.13 | $-1.79 | ||
| Q1 25 | $-0.16 | $-0.15 | ||
| Q4 24 | $-0.57 | $-15.29 | ||
| Q3 24 | $0.00 | $-18.24 | ||
| Q2 24 | $-0.01 | $-71.81 | ||
| Q1 24 | $-0.01 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $447.5M | $48.9M |
| Total DebtLower is stronger | $483.8M | — |
| Stockholders' EquityBook value | $355.7M | $-249.4M |
| Total Assets | $2.3B | $308.9M |
| Debt / EquityLower = less leverage | 1.36× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $447.5M | $48.9M | ||
| Q3 25 | $346.3M | $43.1M | ||
| Q2 25 | $308.2M | $40.8M | ||
| Q1 25 | $241.4M | $58.6M | ||
| Q4 24 | $391.2M | $56.3M | ||
| Q3 24 | $51.9M | $75.4M | ||
| Q2 24 | $64.3M | $89.6M | ||
| Q1 24 | $59.3M | $112.8M |
| Q4 25 | $483.8M | — | ||
| Q3 25 | $508.6M | — | ||
| Q2 25 | $491.5M | — | ||
| Q1 25 | $502.7M | — | ||
| Q4 24 | $511.4M | — | ||
| Q3 24 | $394.4M | — | ||
| Q2 24 | $393.1M | — | ||
| Q1 24 | $398.7M | — |
| Q4 25 | $355.7M | $-249.4M | ||
| Q3 25 | $364.8M | $-235.7M | ||
| Q2 25 | $360.9M | $-214.1M | ||
| Q1 25 | $344.3M | $-417.5M | ||
| Q4 24 | $358.9M | $-398.4M | ||
| Q3 24 | $394.1M | $-344.1M | ||
| Q2 24 | $383.0M | $-203.2M | ||
| Q1 24 | $377.1M | $371.6M |
| Q4 25 | $2.3B | $308.9M | ||
| Q3 25 | $2.2B | $362.6M | ||
| Q2 25 | $1.9B | $379.2M | ||
| Q1 25 | $1.7B | $405.1M | ||
| Q4 24 | $1.7B | $437.4M | ||
| Q3 24 | $917.6M | $537.8M | ||
| Q2 24 | $926.2M | $691.5M | ||
| Q1 24 | $917.0M | $1.3B |
| Q4 25 | 1.36× | — | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.36× | — | ||
| Q1 25 | 1.46× | — | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 1.03× | — | ||
| Q1 24 | 1.06× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.9M | $8.2M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.9M | $8.2M | ||
| Q3 25 | $236.0M | $11.4M | ||
| Q2 25 | $157.9M | $-21.3M | ||
| Q1 25 | $51.9M | $8.5M | ||
| Q4 24 | $340.7M | $-14.7M | ||
| Q3 24 | $32.0M | $-9.4M | ||
| Q2 24 | $36.7M | $-11.9M | ||
| Q1 24 | $29.8M | $-621.0K |
| Q4 25 | — | — | ||
| Q3 25 | 216.53× | — | ||
| Q2 25 | 8.22× | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 3.23× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSAT
| Services | $67.4M | 94% |
| Products | $4.6M | 6% |
STEM
Segment breakdown not available.
